A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity
Cancer Cell · 2026-11 · 44 (11) · 2227-2248.e21
DOI: 10.1016/j.ccell.2026.10.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-11. Verfasst von Dong Woo Kang und 19 weiteren Autor:innen. Beteiligte Einrichtung: MedPacto, Inc., Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Transforming Growth Factor beta, Cancer-Associated Fibroblasts, Neoplasms. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Drug Development Fund.
Abstract (Originalsprache)
Transforming growth factor β (TGF-β) accumulation in the tumor microenvironment (TME) is a major barrier to durable antitumor immunity. We developed fibronectin extra domain B (FN-EDB)-binding peptide (FEBP)-soluble TβRII-Fc (sTβRII), an engineered inhibitor targeting the FN-EDB-rich tumor matrix for localized TGF-β blockade. In fibrotic, immune-excluded tumors, FEBP-sTβRII suppresses TGF-β/SMAD signaling to unleash T cell activation and IFN-γ production, thereby driving feedforward cancer-associated fibroblast (CAF)-myeloid reprogramming toward an antigen-presenting state. This coordinated remodeling relieves immune exclusion and converts the fibrotic TME into an antigen-visible ecosystem that sustains robust T cell infiltration and activation. Consequently, FEBP-sTβRII induces T cell-dependent tumor regression, expands effector-memory populations, and elicits long-term, cross-protective antitumor immunity, while minimizing peripheral transcriptional disturbances compared with systemic sTβRII. Together, these findings show that spatially targeted TGF-β blockade overcomes fibrotic immune exclusion to establish durable local and systemic tumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- MedPacto, Inc., Seoul, Republic of Korea.
- GILO Institute, GILO Foundation, Seoul, Republic of Korea.
- Department of Bioinformatics, Soongsil University, Dongjak-gu, Seoul, Republic of Korea.
- Department of Applied Statistics, Chung-Ang University, Seoul, Republic of Korea.
- Department of Urology, Yale School of Medicine, New Haven, CT, USA.
- YiPSCELL Inc., Seoul, Republic of Korea.
Förderung
- Korea Drug Development Fund
Zitieren
APA
Kang, D. W., Bae, J. B., Yoo, S., Kim, H., Kim, P., Mo, J., Kim, J., Kim, J. S., Yoon, K., Kim, Y. S., Lee, J. S., Kim, J. M., Kang, M. G., Lee, M. J., Lim, C., Kim, I. Y., Hong, C. P., Kim, J., Letterio, J. J., & Kim, S. J. (2026). A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity. Cancer Cell, 44(11), 2227-2248.e21. https://doi.org/10.1016/j.ccell.2026.10.007
Vancouver
Kang DW, Bae JB, Yoo S, Kim H, Kim P, Mo J, et al. A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity. Cancer Cell. 2026;44(11):2227-2248.e21. doi:10.1016/j.ccell.2026.10.007
BibTeX
@article{Kang2026,
author = {Kang, Dong Woo and Bae, Jin Beom and Yoo, Seonho and Kim, Hyejin and Kim, Pyunggang and Mo, Jaewoo and Kim, Jinhwan and Kim, Jin Su and Yoon, Kwiyeom and Kim, Ye Seon and Lee, Jeong Su and Kim, June Myoung and Kang, Min Gi and Lee, Min Jung and Lim, Changwon and Kim, Isaac Y and Hong, Chang Pyo and Kim, Junil and Letterio, John J and Kim, Seong-Jin},
title = {A stroma-sensing TGF-β blockade reprograms CAF-myeloid niches to induce durable tumor immunity},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {11},
pages = {2227--2248.e21},
doi = {10.1016/j.ccell.2026.10.007}
}
EUVIMED